Life Scientist > Biotechnology

TGA approves psychedelics for mental health treatment

06 February, 2023 by Lauren Davis

From 1 July this year, the TGA will permit the prescribing of MDMA for post-traumatic stress disorder and psilocybin for treatment-resistant depression.


Artificial DNA kills cancer cells

26 January, 2023

Researchers developed a chemically synthesised, hairpin-shaped DNA strand that can activate a natural immune response to target and kill specific cancerous cells.


Light therapy eliminates antibiotic-resistant superbugs

23 January, 2023

The photodynamic technology harnesses the energy of light to generate highly reactive oxygen molecules that eradicate microbial cells and kill deadly bacteria.


Queensland invests in global mRNA vaccine hub

08 December, 2022

Sanofi has partnered with the Queensland Government, The University of Queensland and Griffith University to inject $280 million into a next-generation mRNA vaccine research hub.


With funding dwindling, how can biotech companies maintain momentum?

06 December, 2022 by Glenn Bilawsky, CEO

Partnering with biopharmaceutical outsourcing companies provides an opportunity for drug and diagnostic developers to better leverage their assets.


Gene therapy trial for type 1 diabetes to proceed

30 November, 2022

The trial is set to be the first time that genetically engineered pancreatic islet cells will be transplanted into humans to treat type 1 diabetes.


$352m plasma therapeutics plant coming to Qld

29 November, 2022

Aegros, which is currently based in Sydney, will establish its global headquarters and a one-million-litre plasma fractionation facility in Springfield's BioPark Australia precinct.


A second chance for UQ's molecular clamp vaccine platform

28 November, 2022

UQ is set to take a second-generation 'molecular clamp' vaccine to a proof-of-concept human trial, after CEPI announced funding to support the technology.


Syringe to improve sperm selection for infertile couples

25 November, 2022

Bioengineering researchers have developed a syringe that uses a 3D filter to detect and isolate viable sperm in less than 15 minutes.


Urine could play a key part in biotech systems

22 November, 2022

A common chemical found in urine can be used to kick-start large-scale production of proteins such as hormones and antibodies used by biotech companies.


Bionic pancreas simplifies type 1 diabetes management

14 November, 2022

Compared to other available artificial pancreas technologies, the bionic pancreas is designed to require less user input and provides more automation.


DNA nanotransporters optimise drug delivery

09 November, 2022

Researchers have designed a new class of drug transporters made of DNA that are 20,000 times smaller than a human hair and could improve how diseases are treated.


Drug found to reduce sleep apnoea severity

09 November, 2022

A drug previously used to treat depression has been found to reduce obstructive sleep apnoea severity.


Breakthrough for drug delivery through blood–brain barrier

28 October, 2022

In a major advance for the treatment of Alzheimer's, Australian scientists have successfully delivered drugs through patient cell models of the human blood–brain barrier.


Five-year project to develop next-gen TB vaccines

10 October, 2022

The Centenary Institute and the University of Sydney have been awarded a $19m contract to develop the next generation of tuberculosis vaccines.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd